Gene amplification and protein overexpression of FLNA in head and neck squamous cell carcinoma

  • 0Material Research Centre, Department of Conservative Dentistry and Endodontics, Saveetha Dental College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, TN, India.

Summary

This summary is machine-generated.

Filamin A (FLNA) gene amplification and overexpression are common in head and neck squamous cell carcinoma (HNSCC). High FLNA levels correlate with advanced disease and poor prognosis, suggesting FLNA as a potential HNSCC biomarker.

Area Of Science

  • Oncology
  • Molecular Biology
  • Genetics

Background

  • Head and neck squamous cell carcinoma (HNSCC) is a prevalent malignancy with known risk factors.
  • Filamin A (FLNA), an actin-binding protein, influences cytoskeletal dynamics, but its role in HNSCC remains under investigation.

Purpose Of The Study

  • To investigate FLNA gene amplification, mRNA, and protein overexpression in HNSCC.
  • To evaluate the clinical significance and prognostic value of FLNA alterations in HNSCC patients.

Main Methods

  • Utilized cBioPortal for genetic alterations and UALCAN for expression analysis (TCGA, CPTAC).
  • Validated FLNA expression via real-time PCR and immunohistochemistry.
  • Performed prognostic analysis using Kaplan-Meier plotter and pathway analysis via Metascape.

Main Results

  • FLNA alterations, predominantly amplification, occurred in 7% of HNSCC patients, correlating with increased mRNA expression.
  • FLNA mRNA and protein were significantly upregulated in HNSCC tissues compared to non-tumor samples.
  • High FLNA expression was linked to advanced stage, higher grade, lymph node metastasis, and reduced overall survival.

Conclusions

  • FLNA amplification and overexpression are potential prognostic biomarkers for HNSCC.
  • FLNA is implicated in key pathways like focal adhesion and cell adhesion, crucial for cancer progression.